Cargando…

Reassessing the evidence for universal school-age BCG vaccination in England and Wales: re-evaluating and updating a modelling study

OBJECTIVES: In 2005, England and Wales switched from universal BCG vaccination against tuberculosis (TB) disease for school-age children to targeted vaccination of neonates. We aimed to recreate and re-evaluate a previously published model, the results of which informed this policy change. DESIGN: W...

Descripción completa

Detalles Bibliográficos
Autores principales: Abbott, Sam, Christensen, Hannah, Brooks-Pollock, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753396/
https://www.ncbi.nlm.nih.gov/pubmed/35017227
http://dx.doi.org/10.1136/bmjopen-2019-031573
_version_ 1784632087567925248
author Abbott, Sam
Christensen, Hannah
Brooks-Pollock, Ellen
author_facet Abbott, Sam
Christensen, Hannah
Brooks-Pollock, Ellen
author_sort Abbott, Sam
collection PubMed
description OBJECTIVES: In 2005, England and Wales switched from universal BCG vaccination against tuberculosis (TB) disease for school-age children to targeted vaccination of neonates. We aimed to recreate and re-evaluate a previously published model, the results of which informed this policy change. DESIGN: We recreated an approach for estimating the impact of ending the BCG schools scheme, correcting a methodological flaw in the model, updating the model with parameter uncertainty and improving parameter estimates where possible. We investigated scenarios for the assumed annual decrease in TB incidence rates considered by the UK’s Joint Committee on Vaccination and Immunisation and explored alternative scenarios using notification data. SETTING: England and Wales. OUTCOME MEASURES: The number of vaccines needed to prevent a single notification and the average annual additional notifications caused by ending the policy change. RESULTS: The previously published model was found to contain a methodological flaw and to be spuriously precise. It greatly underestimated the impact of ending school-age vaccination compared with our updated, corrected model. The updated model produced predictions with wide CIs when parameter uncertainty was included. Model estimates based on an assumption of an annual decrease in TB incidence rates of 1.9% were closest to those estimated using notification data. Using this assumption, we estimate that 1600 (2.5; 97.5% quantiles: 1300, 2000) vaccines would have been required to prevent a single notification in 2004. CONCLUSIONS: The impact of ending the BCG schools scheme was found to be greater than previously thought when notification data were used. Our results highlight the importance of independent evaluations of modelling evidence, including uncertainty, and evaluating multiple scenarios when forecasting the impact of changes in vaccination policy.
format Online
Article
Text
id pubmed-8753396
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-87533962022-01-26 Reassessing the evidence for universal school-age BCG vaccination in England and Wales: re-evaluating and updating a modelling study Abbott, Sam Christensen, Hannah Brooks-Pollock, Ellen BMJ Open Infectious Diseases OBJECTIVES: In 2005, England and Wales switched from universal BCG vaccination against tuberculosis (TB) disease for school-age children to targeted vaccination of neonates. We aimed to recreate and re-evaluate a previously published model, the results of which informed this policy change. DESIGN: We recreated an approach for estimating the impact of ending the BCG schools scheme, correcting a methodological flaw in the model, updating the model with parameter uncertainty and improving parameter estimates where possible. We investigated scenarios for the assumed annual decrease in TB incidence rates considered by the UK’s Joint Committee on Vaccination and Immunisation and explored alternative scenarios using notification data. SETTING: England and Wales. OUTCOME MEASURES: The number of vaccines needed to prevent a single notification and the average annual additional notifications caused by ending the policy change. RESULTS: The previously published model was found to contain a methodological flaw and to be spuriously precise. It greatly underestimated the impact of ending school-age vaccination compared with our updated, corrected model. The updated model produced predictions with wide CIs when parameter uncertainty was included. Model estimates based on an assumption of an annual decrease in TB incidence rates of 1.9% were closest to those estimated using notification data. Using this assumption, we estimate that 1600 (2.5; 97.5% quantiles: 1300, 2000) vaccines would have been required to prevent a single notification in 2004. CONCLUSIONS: The impact of ending the BCG schools scheme was found to be greater than previously thought when notification data were used. Our results highlight the importance of independent evaluations of modelling evidence, including uncertainty, and evaluating multiple scenarios when forecasting the impact of changes in vaccination policy. BMJ Publishing Group 2022-01-11 /pmc/articles/PMC8753396/ /pubmed/35017227 http://dx.doi.org/10.1136/bmjopen-2019-031573 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Infectious Diseases
Abbott, Sam
Christensen, Hannah
Brooks-Pollock, Ellen
Reassessing the evidence for universal school-age BCG vaccination in England and Wales: re-evaluating and updating a modelling study
title Reassessing the evidence for universal school-age BCG vaccination in England and Wales: re-evaluating and updating a modelling study
title_full Reassessing the evidence for universal school-age BCG vaccination in England and Wales: re-evaluating and updating a modelling study
title_fullStr Reassessing the evidence for universal school-age BCG vaccination in England and Wales: re-evaluating and updating a modelling study
title_full_unstemmed Reassessing the evidence for universal school-age BCG vaccination in England and Wales: re-evaluating and updating a modelling study
title_short Reassessing the evidence for universal school-age BCG vaccination in England and Wales: re-evaluating and updating a modelling study
title_sort reassessing the evidence for universal school-age bcg vaccination in england and wales: re-evaluating and updating a modelling study
topic Infectious Diseases
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753396/
https://www.ncbi.nlm.nih.gov/pubmed/35017227
http://dx.doi.org/10.1136/bmjopen-2019-031573
work_keys_str_mv AT abbottsam reassessingtheevidenceforuniversalschoolagebcgvaccinationinenglandandwalesreevaluatingandupdatingamodellingstudy
AT christensenhannah reassessingtheevidenceforuniversalschoolagebcgvaccinationinenglandandwalesreevaluatingandupdatingamodellingstudy
AT brookspollockellen reassessingtheevidenceforuniversalschoolagebcgvaccinationinenglandandwalesreevaluatingandupdatingamodellingstudy